Skip to content

Clinical trials

Completed Phase 3 Thrombocythemia, Essential trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocythemia, Essential Phase: Phase 3 Status: Completed Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20021
20051
20071
20082
20103
20111
20121
20141

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AOP Orphan Pharmaceuticals AG3
Alliance for Clinical Trials in Oncology2
Memorial Sloan Kettering Cancer Center2
Shire2
Case Comprehensive Cancer Center1
European Organisation for Research and Treatment of Cancer - EORTC1
INSYS Therapeutics Inc1
Jonsson Comprehensive Cancer Center1
NCIC Clinical Trials Group1
Ronald Hoffman1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocythemia, Essential17
Polycythemia Vera11
Primary Myelofibrosis11
Blast Crisis10
Burkitt Lymphoma10
Hodgkin Disease10
Immunoblastic Lymphadenopathy10
Immunoglobulin Light-chain Amyloidosis10
Leukemia, Hairy Cell10
Leukemia, Lymphocytic, Chronic, B-Cell10

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.